Company news
Pathkey.ai Limited (ASX:PKY) news
Pathkey.ai Limited news releases on 6ix. Latest, Feb 8, 2024: Successful Placement of Rights Issue Shortfall
Press releases — page 2
Successful Placement of Rights Issue Shortfall
February 7, 2024
Opin Signs New $282K Patient Recruitment Contract
February 4, 2024
Rights Offer Booklet
December 21, 2023
Opyl Opens Rights Offer
December 21, 2023
Opyl completes Placement and launches Entitlement Offer
December 12, 2023
Opyl Appoints Chief Executive Officer
November 23, 2023
Opyl Receives $530K R&D Tax Refund
September 21, 2023
TrialKey MVP Launched / Strategy Update Webcast
August 24, 2023
Opyl Announces Leadership Changes & Strategic Realignment
July 5, 2023
Opyl completes Placement and secures short term loan
July 3, 2023
Successful Placement of Shortfall Shares from Rights Issue
April 4, 2023
Appendix 4D & Half Year Results
February 26, 2023
Opyl enters into MSA and new clinical trial recruitment
January 17, 2023
Opyl completes Placement and launches Rights Issue
December 23, 2022
Suspension from Official Quotation
December 23, 2022
Opyl - world-first mapping & linking clinical trial data
October 19, 2022
Opyl Receives $570K R&D Tax Refund
October 18, 2022
Opyl - Appendix 4E & Annual Report
August 30, 2022
Opyl - FY22 Results Announcement
August 30, 2022
Opyl 2021 AGM Presentation 18 November 2021
November 18, 2021
Opyl - August Full Year Investor Update
August 30, 2021
Opyl 2021 Appendix 4E & Annual Report
August 26, 2021
Opyl - Opin enters global strategic alliance
July 2, 2021
Opyl - Investor presentation introducing Opin
May 24, 2021
Introducing Opin - match patients to clinical trials
May 21, 2021
Opyl - Clarification Statement to Appendix 4C
May 19, 2021
Opyl - Completes successful SPP
April 21, 2021
Opyl - Clinical trial recruitment platform update
April 15, 2021
Opyl - Completes Unmarketable Share Buyback
April 8, 2021
Opyl - Capital Raising Completed & Cleansing Notice
April 6, 2021
Opyl - Completes Capital Raise and Launches SPP
March 30, 2021
Opyl - Half Year Investor Presentation
February 24, 2021
Opyl 2020 AGM Presentation
November 30, 2020
Opyl receives $249k R&D tax refund
November 26, 2020
Reinstatement to Official Quotation
September 7, 2020
Opyl achieves major milestone with AI platform
September 2, 2020
Opyl - Appendix 4E & Full Year Statutory Accounts
August 28, 2020
Opyl - Business Update and Appendix 4C
July 26, 2020
Opyl - Capital Raise Completed & Cleansing Notice
June 24, 2020
Opyl - Completes Capital Raise
June 19, 2020
Opyl - Additional Information for 20 May Announcement
May 25, 2020
Opyl - Commercial Update
May 20, 2020
Opyl - Updated March Quarter Appendix 4C
May 15, 2020
Opyl and AAMRI launch COVID-19 Social Media Guide
May 12, 2020
Opyl - Additional Commentary March Quarter 2020
May 11, 2020
Opyl receives $201K R&D incentive and tax refund
April 30, 2020
Opyl - Business Update & Half Year Report
February 28, 2020
Response to ASX Appendix 4C Query
February 27, 2020
Opyl develops clinical trial prediction software using AI
February 18, 2020
Opyl partners with hummun
February 10, 2020